Long-Term Outcome for Patients With High Volume Retroperitoneal Teratoma Undergoing Post-Chemotherapy Surgery

Journal of Urology

Volumn 181, Issue 6, 2009, Pages 2526-2532

  Beck, Stephen D W ^a   Foster, Richard S ^a   Bihrle, Richard ^a   Einhorn, Lawrence H ^a   Donohue, John P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lymph node excision; teratoma; testicular neoplasms

Indexed keywords

ADULT; ARTICLE; CANCER CHEMOTHERAPY; DEATH; DISEASE FREE SURVIVAL; HUMAN; LUNG METASTASIS; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; RETROSPECTIVE STUDY; SEPSIS; TERATOMA; TESTIS CANCER; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; COMBINED MODALITY THERAPY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; TERATOMA; TESTICULAR NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67349191557     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.01.116     Document Type: Article

References (17)

1. Loehrer Sr. P.J., Hui S., Clark S., Seal M., Einhorn L.H., Williams S.D., et al. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation. J Urol 135 (1986) 1183
2. Carver B.S., Shayegan B., Serio A., Motzer R.J., Bosl G.J., and Sheinfeld J. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol 25 (2007) 1033
3. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15 (1997) 594
4. Dindo D., Demartines N., and Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004) 205
5. Aprikian A.G., Herr H.W., Bajorin D.F., and Bosl G.J. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer 74 (1994) 1329
6. Davey D.D., Ulbright T.M., Loehrer P.J., Einhorn L.H., Donohue J.P., and Williams S.D. The significance of atypia within teratomatous metastases after chemotherapy for malignant germ cell tumors. Cancer 59 (1987) 533
7. Donohue J.P., Roth L.M., Zachary J.M., Rowland R.G., Einhorn L.H., and Williams S.G. Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy. J Urol 127 (1982) 1111
8. Fossa S.D., Aass N., Ous S., Hoie J., Stenwig A.E., Lien H.H., et al. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. J Urol 142 (1989) 1239
9. Jansen R.L., Sylvester R., Sleyfer D.T., ten BokkelHuinink W.W., Kaye S.B., Jones W.G., et al. Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. EORTC Genitourinary Tract Cancer Cooperative Group (EORTC GU Group). Eur J Cancer 27 (1991) 695
10. Kulkarni R.P., Reynolds K.W., Newlands E.S., Dawson P.M., Makey A.R., Theodorou N.A., et al. Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis. Br J Surg 78 (1991) 226
11. Sella A., el Naggar A., Ro J.Y., Dexeus F.H., Amato R.J., Lee J.S., et al. Evidence of malignant features in histologically mature teratoma. J Urol 146 (1991) 1025
12. Sonneveld D.J., Sleijfer D.T., Koops H.S., Keemers-Gels M.E., Molenaar W.M., and Hoekstra H.J. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer 82 (1998) 1343
13. Tait D., Peckham M.J., Hendry W.F., and Goldstraw P. Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 50 (1984) 601
14. Steyerberg E.W., Keizer H.J., Messemer J.E., Toner G.C., Schraffordt Koops H., Fossa S.D., et al. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group. Cancer 79 (1997) 345
15. Tognoni P.G., Foster R.S., McGraw P., Heilman D., Bihrle R., Rowland R.G., et al. Combined post-chemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on morbidity and tumor pathology. J Urol 159 (1998) 1833
16. Jacobsen N.B., Foster R.S., Beck S.D.W., Bihrle R., Einhorn L.H., and Donohue J.P. Is retroperitoneal histology predictive of liver histology at the time of concurrent post-chemotherapy retroperitoneal lymph node dissection and hepatic resection?. J Urol 175 suppl (2006) 191 abstract 588
17. Donohue J.P. Retroperitoneal lymphadenectomy: the anterior approach including bilateral suprarenal-hilar dissection. Urol Clin North Am 4 (1977) 509